A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up

Alessia Bari, Raffaella Marcheselli, Luigi Marcheselli, Maria Isabel Alvarez De Celis, Samantha Pozzi, Paola Ferri, Antonio Lazzaro, Alberto Fragasso, Santo Neri, Luca Baldini, Angelo Michele Carella, Francesco Angrilli, Roberto Guariglia, Gabriele Buda, Caterina Stelitano, Stefano Sacchi, Gruppo Italiano Studio Linfomi (GISL)

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up'. Together they form a unique fingerprint.

Medicine & Life Sciences